The Potential Use of Mesenchymal Stem Cells-Derived Exosomes As Micrornas Delivery Systems in Different Diseases Publisher Pubmed



Oveili E¹ ; Vafaei S² ; Bazavar H³ ; Eslami Y⁴ ; Mamaghanizadeh E³ ; Yasamineh S⁵ ; Gholizadeh O^{3, 6, 7} Show Affiliations
Source: Cell Communication and Signaling Published:2023

Abstract

MicroRNAs (miRNAs) are a group of small non-coding RNAs that regulate gene expression by targeting mRNA. Moreover, it has been shown that miRNAs expression are changed in various diseases, such as cancers, autoimmune disease, infectious diseases, and neurodegenerative Diseases. The suppression of miRNA function can be easily attained by utilizing of anti-miRNAs. In contrast, an enhancement in miRNA function can be achieved through the utilization of modified miRNA mimetics. The discovery of appropriate miRNA carriers in the body has become an interesting subject for investigators. Exosomes (EXOs) therapeutic efficiency and safety for transferring different cellular biological components to the recipient cell have attracted significant attention for their capability as miRNA carriers. Mesenchymal stem cells (MSCs) are recognized to generate a wide range of EXOs (MSC-EXOs), showing that MSCs may be effective for EXO generation in a clinically appropriate measure as compared to other cell origins. MSC-EXOs have been widely investigated because of their immune attributes, tumor-homing attributes, and flexible characteristics. In this article, we summarized the features of miRNAs and MSC-EXOs, including production, purification, and miRNA loading methods of MSC-EXOs, and the modification of MSC-EXOs for targeted miRNA delivery in various diseases. Graphical abstract: [Figure not available: see fulltext.] [MediaObject not available: see fulltext.]. © 2023, The Author(s).